A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2004
11/03/2004	EP1472375A1 Gene products differentially expressed in cancerous breast cells and their methods of use
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472337A1 Induction of tumor immunity by variants of folate binding protein
11/03/2004	EP1472287A1 Rhamnose binding protein
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472266A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471937A1 A continuous cell line for the production of vaccines
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471873A2 Flavivirus vaccines
11/03/2004	EP1471853A2 Medical device with coating that promotes endothelial cell adherence and differentiation
11/03/2004	EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004	EP1131094B1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus
11/03/2004	EP1082436B1 Moraxella catarrhalis pilq proteins
11/03/2004	EP1071400B1 Drug delivery of proteins from polymeric blends
11/03/2004	EP0921813B1 Immunogenic preparation and method for improving the productivity of ruminant animals
11/03/2004	EP0698216B1 Methods of typing hepatitis c virus and reagents for use therein
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	CN1543569A Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes
11/03/2004	CN1543476A Methods and compounds for the targeting of protein to exosomes
11/03/2004	CN1543350A Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1542020A Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1541713A Cross-breed vaccine carrier and its application
11/03/2004	CN1541710A Bivalence polypeptide vaccine for resisting A type and O type foot-and-mouth disease virus and its preparation
11/03/2004	CN1541709A Polyepitope and composite polyepitope DNA vaccine of HIV
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1174099C Nucleic acid vaccines encoding G protein of respiratory syncytial virus
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173741C Concatenated antidiotype monoclonic antibody vaccine for fish diseases
11/03/2004	CN1173740C Passively administered antibody that enhances feed conversion efficiency
11/03/2004	CN1173736C Use of interleukin-18 inhibitors in inhibiting tumor metastasis
11/03/2004	CN1173735C Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812024 Immunization of preferential animal; obtain animal, inject with antigen, allow for formation of antibodies, recover antibodies
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6811787 Over-expressing homologous antigen vaccine and a method of making the same
11/02/2004	US6811785 Multivalent MHC class II—peptide chimeras
11/02/2004	US6811784 Recombinant parainfluenza virus expression system and vaccines
11/02/2004	US6811783 Immunogenic compositions for protection against chlamydial infection
11/02/2004	US6811782 Peptide composition as immunogen for the treatment of allergy
11/02/2004	US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004	US6811780 Concurrent administering of cytokine antagonist and vaccine
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	CA2277554C Streptokinase mutants
11/02/2004	CA2138921C Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it
10/2004
10/28/2004	WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004	WO2004092373A1 Peptide having htlv-1-specific ctl-inducing activity
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092343A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
10/28/2004	WO2004092332A2 Sars virus polypeptides
10/28/2004	WO2004092221A1 Immunogen, composition for immunological use and process for producing antibody using the same
10/28/2004	WO2004092216A1 Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
10/28/2004	WO2004092212A2 Tumor antigens bfa5 for prevention and/or treatment of cancer
10/28/2004	WO2004092210A2 Molecules having immunomodulatory activity
10/28/2004	WO2004092209A2 S. pneumoniae antigens
10/28/2004	WO2004092208A2 Sars-related proteins
10/28/2004	WO2004092207A2 Respiratory syncytial virus (rsv) peptides
10/28/2004	WO2004092201A2 Enhanced hiv-1 vaccines and methods for their use
10/28/2004	WO2004091658A1 High concentration antibody and protein formulations
10/28/2004	WO2004091656A2 Stabilising formulation for immunoglobulin g compositions in liquid form and in lyophilised form
10/28/2004	WO2004091551A2 Anti-tumor vasculature effects of human serum albumin derivatives
10/28/2004	WO2004091550A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
10/28/2004	WO2004091543A2 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
10/28/2004	WO2004091524A2 Respiratory virus vaccines
10/28/2004	WO2004091520A2 Methods and compositions for treating atherosclerosis
10/28/2004	WO2004091519A2 Methods of preventing or treating respiratory conditions
10/28/2004	WO2004091510A2 Recombinant il-9 antibodies and uses thereof
10/28/2004	WO2004091507A2 Optimal polyvalent vaccine for cancer
10/28/2004	WO2004091500A2 Delivery of immune response modifier compounds
10/28/2004	WO2004091491A2 Profiling conformational variants, antibody compositions and methods of using the same
10/28/2004	WO2004091375A2 Epha2 and non-neoplastic hyperproliferative cell disorders
10/28/2004	WO2004083375A3 Methods of promoting the differentiation of stem cells
10/28/2004	WO2004080490A3 Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
10/28/2004	WO2004078099A3 Compositions and methods for the generation of protective immune response against malaria
10/28/2004	WO2004073738A3 Composition to be administered to a living being and method for marking agents
10/28/2004	WO2004072651A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f)
10/28/2004	WO2004069205A3 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
10/28/2004	WO2004062560A3 Pharmaceutical composition
10/28/2004	WO2004060145A3 Isolation and identification of cross-reactive t cells
10/28/2004	WO2004058806A3 Inclusion bodies as antigens for the oral vaccination of animals against csfv
10/28/2004	WO2004058292A3 Methods and compositions for suppressing fibrocyte differentiation
10/28/2004	WO2004055190A3 Immunization of fish with plant-expressed recombinant proteins
10/28/2004	WO2004053454A3 Methods for detecting invasion of a cell
10/28/2004	WO2004052922A3 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage

1 ... 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 ... 1823